About us Pricing ContactSubscribe

S

S. Meadows–Shropshire

Bristol-Myers Squibb (United States)

h-index

—

Publications

—

Citations

—

i10-index

—

Impact (2-yr)

—

Top Publications

First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial

The Lancet Oncology20211,333 citations

S. Meadows–Shropshire · Scinovex